The Use of Blood-Based Biomarkers in the Prediction of Colorectal Neoplasia at the Time of Primary Screening Colonoscopy Among Average-Risk Patients: A Systematic Literature Review.

MLA

Sutherland, R.Liam, et al. “The Use of Blood-Based Biomarkers in the Prediction of Colorectal Neoplasia at the Time of Primary Screening Colonoscopy Among Average-Risk Patients: A Systematic Literature Review.” Cancers, vol. 16, no. 22, Nov. 2024, p. 3824. EBSCOhost, https://doi.org/10.3390/cancers16223824.

APA

Sutherland, R. L., O’Sullivan, D. E., Ruan, Y., Chow, K., Mah, B., Kim, D., Basmadjian, R. B., Forbes, N., Cheung, W. Y., Hilsden, R. J., & Brenner, D. R. (2024). The Use of Blood-Based Biomarkers in the Prediction of Colorectal Neoplasia at the Time of Primary Screening Colonoscopy Among Average-Risk Patients: A Systematic Literature Review. Cancers, 16(22), 3824. https://doi.org/10.3390/cancers16223824

Chicago

Sutherland, R. Liam, Dylan E. O’Sullivan, Yibing Ruan, Kristian Chow, Brittany Mah, Dayoung Kim, Robert B. Basmadjian, et al. 2024. “The Use of Blood-Based Biomarkers in the Prediction of Colorectal Neoplasia at the Time of Primary Screening Colonoscopy Among Average-Risk Patients: A Systematic Literature Review.” Cancers 16 (22): 3824. doi:10.3390/cancers16223824.